These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

6275 related items for PubMed ID: 9742976

  • 1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep 12; 352(9131):837-53. PubMed ID: 9742976
    [Abstract] [Full Text] [Related]

  • 2. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep 12; 352(9131):854-65. PubMed ID: 9742977
    [Abstract] [Full Text] [Related]

  • 3. United Kingdom Prospective Diabetes Study (UKPDS). 13: Relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years.
    BMJ; 1995 Jan 14; 310(6972):83-8. PubMed ID: 7833731
    [Abstract] [Full Text] [Related]

  • 4. UKPDS 26: Sulphonylurea failure in non-insulin-dependent diabetic patients over six years. UK Prospective Diabetes Study (UKPDS) Group.
    Matthews DR, Cull CA, Stratton IM, Holman RR, Turner RC.
    Diabet Med; 1998 Apr 14; 15(4):297-303. PubMed ID: 9585394
    [Abstract] [Full Text] [Related]

  • 5. 10-year follow-up of intensive glucose control in type 2 diabetes.
    Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA.
    N Engl J Med; 2008 Oct 09; 359(15):1577-89. PubMed ID: 18784090
    [Abstract] [Full Text] [Related]

  • 6. Post-trial monitoring of a randomised controlled trial of intensive glycaemic control in type 2 diabetes extended from 10 years to 24 years (UKPDS 91).
    Adler AI, Coleman RL, Leal J, Whiteley WN, Clarke P, Holman RR.
    Lancet; 2024 Jul 13; 404(10448):145-155. PubMed ID: 38772405
    [Abstract] [Full Text] [Related]

  • 7. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb 01; 128(3):165-75. PubMed ID: 9454524
    [Abstract] [Full Text] [Related]

  • 8. United Kingdom prospective diabetes study (UKPDS): what now or so what?
    Leslie RD.
    Diabetes Metab Res Rev; 1999 Feb 01; 15(1):65-71. PubMed ID: 10398549
    [Abstract] [Full Text] [Related]

  • 9. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ, Bailey CJ.
    Drugs; 2005 Feb 01; 65(3):385-411. PubMed ID: 15669880
    [Abstract] [Full Text] [Related]

  • 10. UKPDS 28: a randomized trial of efficacy of early addition of metformin in sulfonylurea-treated type 2 diabetes. U.K. Prospective Diabetes Study Group.
    Diabetes Care; 1998 Jan 01; 21(1):87-92. PubMed ID: 9538975
    [Abstract] [Full Text] [Related]

  • 11. The use of sulphonylureas in the elderly.
    Graal MB, Wolffenbuttel BH.
    Drugs Aging; 1999 Dec 01; 15(6):471-81. PubMed ID: 10641958
    [Abstract] [Full Text] [Related]

  • 12. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC, Cull CA, Frighi V, Holman RR.
    JAMA; 1999 Jun 02; 281(21):2005-12. PubMed ID: 10359389
    [Abstract] [Full Text] [Related]

  • 13. Comparison of diabetic control in type 2 (non-insulin dependent) diabetic patients treated with different sulphonylureas.
    Harrower AD.
    Curr Med Res Opin; 1985 Jun 02; 9(10):676-80. PubMed ID: 3935376
    [Abstract] [Full Text] [Related]

  • 14. Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus.
    Fullerton B, Jeitler K, Seitz M, Horvath K, Berghold A, Siebenhofer A.
    Cochrane Database Syst Rev; 2014 Feb 14; 2014(2):CD009122. PubMed ID: 24526393
    [Abstract] [Full Text] [Related]

  • 15. United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.
    Turner R, Cull C, Holman R.
    Ann Intern Med; 1996 Jan 01; 124(1 Pt 2):136-45. PubMed ID: 8554206
    [Abstract] [Full Text] [Related]

  • 16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL, Figgitt DP.
    Pharmacoeconomics; 2004 Jan 01; 22(6):389-411. PubMed ID: 15099124
    [Abstract] [Full Text] [Related]

  • 17. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group.
    Diabetes; 1995 Nov 01; 44(11):1249-58. PubMed ID: 7589820
    [Abstract] [Full Text] [Related]

  • 18. Glyburide and glipizide in treatment of diabetic patients with secondary failures to tolazamide or chlorpropamide.
    Lev JD, Zeidler A, Kumar D.
    Diabetes Care; 1987 Nov 01; 10(6):679-82. PubMed ID: 3123183
    [Abstract] [Full Text] [Related]

  • 19. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes.
    Abraira C, Colwell JA, Nuttall FQ, Sawin CT, Nagel NJ, Comstock JP, Emanuele NV, Levin SR, Henderson W, Lee HS.
    Diabetes Care; 1995 Aug 01; 18(8):1113-23. PubMed ID: 7587846
    [Abstract] [Full Text] [Related]

  • 20. U.K. prospective diabetes study. II. Reduction in HbA1c with basal insulin supplement, sulfonylurea, or biguanide therapy in maturity-onset diabetes. A multicenter study.
    Diabetes; 1985 Aug 01; 34(8):793-8. PubMed ID: 2862087
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 314.